Raymond James Lifts Earnings Estimates for HLS Therapeutics
HLS Therapeutics Inc. (TSE:HLS – Free Report) – Research analysts at Raymond James increased their Q2 2025 earnings estimates for HLS Therapeutics in a research note issued on Monday, May 12th. Raymond James analyst M. Freeman now forecasts that the company will earn ($0.10) per share for the quarter, up from their previous forecast of […]
HLS Therapeutics Inc. (TSE:HLS – Free Report) – Research analysts at Raymond James increased their Q2 2025 earnings estimates for HLS Therapeutics in a research note issued on Monday, May 12th. Raymond James analyst M. Freeman now forecasts that the company will earn ($0.10) per share for the quarter, up from their previous forecast of […]
